Beyond the cytotoxic properties, conventional anti-neoplastic agents as well as anti-VEGF therapy also have the ability to stimulate the innate and acquired immune system, and in some instances even to evoke long-term protective memory T cell responses, thus facilitating tumor eradication (14). This evidence concerns the gene VEGFA and neoplasm.